JP2017520364A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520364A5
JP2017520364A5 JP2017519960A JP2017519960A JP2017520364A5 JP 2017520364 A5 JP2017520364 A5 JP 2017520364A5 JP 2017519960 A JP2017519960 A JP 2017519960A JP 2017519960 A JP2017519960 A JP 2017519960A JP 2017520364 A5 JP2017520364 A5 JP 2017520364A5
Authority
JP
Japan
Prior art keywords
carbon dioxide
fluticasone
vol
equipment according
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017519960A
Other languages
English (en)
Japanese (ja)
Other versions
JP6785227B2 (ja
JP2017520364A (ja
Filing date
Publication date
Priority claimed from US14/315,132 external-priority patent/US11554229B2/en
Application filed filed Critical
Priority claimed from PCT/EP2015/064463 external-priority patent/WO2015197798A1/en
Publication of JP2017520364A publication Critical patent/JP2017520364A/ja
Publication of JP2017520364A5 publication Critical patent/JP2017520364A5/ja
Application granted granted Critical
Publication of JP6785227B2 publication Critical patent/JP6785227B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017519960A 2014-06-25 2015-06-25 経鼻投与 Active JP6785227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/315,132 2014-06-25
US14/315,132 US11554229B2 (en) 2013-03-26 2014-06-25 Nasal administration
PCT/EP2015/064463 WO2015197798A1 (en) 2014-06-25 2015-06-25 Nasal administration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020115917A Division JP7090124B2 (ja) 2014-06-25 2020-07-03 経鼻投与

Publications (3)

Publication Number Publication Date
JP2017520364A JP2017520364A (ja) 2017-07-27
JP2017520364A5 true JP2017520364A5 (enExample) 2018-08-16
JP6785227B2 JP6785227B2 (ja) 2020-11-18

Family

ID=53489954

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017519960A Active JP6785227B2 (ja) 2014-06-25 2015-06-25 経鼻投与
JP2020115917A Active JP7090124B2 (ja) 2014-06-25 2020-07-03 経鼻投与

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020115917A Active JP7090124B2 (ja) 2014-06-25 2020-07-03 経鼻投与

Country Status (14)

Country Link
EP (2) EP4233950B1 (enExample)
JP (2) JP6785227B2 (enExample)
KR (1) KR102458964B1 (enExample)
CN (1) CN106470724A (enExample)
AU (3) AU2015279154A1 (enExample)
BR (1) BR112016029926A2 (enExample)
CA (1) CA2953207A1 (enExample)
ES (1) ES3034743T3 (enExample)
IL (1) IL249585B (enExample)
MX (1) MX390453B (enExample)
RU (1) RU2016152090A (enExample)
SG (1) SG11201610685XA (enExample)
WO (1) WO2015197798A1 (enExample)
ZA (1) ZA201608785B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201713899D0 (en) * 2017-08-30 2017-10-11 Indosys Ltd Multi-dose medicament delivery device
US11744967B2 (en) * 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN108421138A (zh) * 2017-12-25 2018-08-21 宫本海 一种鼻腔雾化吸药器
EP3793436B1 (en) * 2018-05-16 2024-07-17 Massachusetts Institute of Technology Apparatus for passive, proportional, valveless gas sampling and delivery
US12478292B2 (en) 2019-10-28 2025-11-25 The Research Foundation For The State University Of New York Devices, systems, and methods of monitoring arterial carbon dioxide

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
GB0121568D0 (en) * 2001-09-06 2001-10-24 Optinose As Nasal delivery device
BR0008650B1 (pt) 1999-03-03 2010-12-28 dispositivo de transmissão via nasal.
EP1218049B1 (en) 1999-07-12 2006-09-20 Capnia Incorporated Apparatus for relieving headaches, rhinitis and other common ailments
US20070039615A1 (en) * 1999-11-08 2007-02-22 Capnia, Incorporated Methods and apparatus for treating rhinitis
JP2003518484A (ja) 1999-12-24 2003-06-10 グラクソ グループ リミテッド サルメテロールおよびプロピオン酸フルチカゾンの医薬用エアゾル製剤
US6652479B2 (en) 2000-02-28 2003-11-25 Capnia, Inc. Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
ZA200306564B (en) * 2001-02-26 2004-10-15 Optinose As Nasal devices.
GB2403154B (en) * 2002-04-04 2007-01-24 Optinose As Nasal devices
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
GB0320171D0 (en) * 2003-08-28 2003-10-01 Optinose As Delivery devices
CN1874756B (zh) * 2003-08-29 2012-02-29 葛兰素集团有限公司 药用计量剂量吸入器和其相关方法
WO2006017505A2 (en) 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
GB0503738D0 (en) * 2005-02-23 2005-03-30 Optinose As Powder delivery devices
GB0602980D0 (en) * 2006-02-14 2006-03-29 Optinose As Delivery device and method
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB2440316A (en) * 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
JP5415769B2 (ja) * 2006-12-26 2014-02-12 株式会社新日本科学 経鼻投与用製剤
GB2448193A (en) * 2007-04-05 2008-10-08 Optinose As Nasal delivery device
GB0719299D0 (en) * 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
JP2011510964A (ja) * 2008-02-01 2011-04-07 ヴェクトゥラ リミテッド トリプタン類の肺用製剤
US20100196483A1 (en) * 2009-02-04 2010-08-05 Activaero Gmbh Research & Development Method for treatmentof severe and uncontrollable asthma
DE102011103347B4 (de) * 2011-05-27 2014-10-30 Meda Pharma Gmbh & Co. Kg Nasale pharmazeutische Formulierung
CN104220123B (zh) * 2012-02-16 2017-08-25 卡普尼亚公司 带扩散鼻件的气体分配器
BR112015024869A8 (pt) * 2013-03-26 2019-12-17 Optinose As uso de um agente terapêutico e/ou de diôxido de carbono para tratar um paciente e aparelhos e métodos para tratar terapeuticamente um paciente

Similar Documents

Publication Publication Date Title
RU2015145449A (ru) Интраназальное введение
JP2017520364A5 (enExample)
KR101488025B1 (ko) 스프레이용 겔 타입 피부/점막-부착형 제제 및 이를 이용한투여 시스템
MX2020012810A (es) Formulación de nicotina.
CN102421474B (zh) 气雾药物输送装置与方法
JP2016040316A5 (enExample)
JP2019089775A (ja) 高濃度の一酸化窒素の投与法
WO2008036801A3 (en) Methods and systems of delivering medication via inhalation
CN101553210A (zh) 经吸入输送药物的方法和系统
ATE451920T1 (de) Pulverinhaliermittel mit sumatriptan und herstellungsverfahren dafür
CN106163598A (zh) 尼古丁粉末吸入器
MX2011012043A (es) Sistema farmaceutico para suministro transmembrana.
RU2016152090A (ru) Интраназальное введение
JP2014513091A5 (enExample)
ES3047545T3 (en) Gas therapy system for delivery of medicament
CN205924634U (zh) 麻醉呼吸回路结构
NZ744942A (en) Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists
JP2020073510A5 (enExample)
WO2015038092A3 (en) Carbon dioxide and saline nasal delivery methods and delivery devices
JP2015536334A5 (enExample)
CN104436386B (zh) 辅助呼吸气雾气体的装置及调节呼吸气雾气体的方法
CN209662361U (zh) 雾化器
CN203226922U (zh) 一种喷鼻装置用可调节双喷头及喷鼻装置
WO2009062193A3 (en) Methods for administering corticosteroid formulations
PH12020552075A1 (en) Hepatitis b vaccine transnasal administration system